sglt2 inhibitors vs glp-1 agonists vs. to Treat the Heart, the Kidneys and the Brain SGLT2 vs GLP-1 for CKD:
Description
Download transcript (PDF) Transcription services provided by 3Play Media.
The WHO also recommended that member countries "reboot" their approaches to obesity care, i.e., improving prevention, treatment and systems-level capacity to address a rapidly growing public-health crisis
Curr Opin Endocrinol Diabetes Obes
Sleep-disordered breathing and lung function abnormalities in adults with congenital heart disease
Previous studies have shown that synaptic plasticity, synaptic transmission, and long-term potentiation (LTP) are dramatically attenuated in the depressive brain (Karpova et al., 2011
